gemcitabine has been researched along with Neoplasms, Nerve Sheath in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergsland, CH; Bruun, J; Danielsen, SA; Eilertsen, IA; Høland, M; Kallioniemi, O; Kolberg, M; Lothe, RA; Mpindi, JP; Murumägi, A | 1 |
1 other study(ies) available for gemcitabine and Neoplasms, Nerve Sheath
Article | Year |
---|---|
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Clinical Trials as Topic; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Nerve Sheath Neoplasms; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Reproducibility of Results; Ribonucleoside Diphosphate Reductase; Tumor Suppressor Proteins | 2017 |